BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

786 related articles for article (PubMed ID: 27318442)

  • 21. [Complete remission after standard induction therapy in a patient with acute myeloid leukemia associated with double-minute chromosomes].
    Goto M; Fukushima N; Iida S; Ito M; Kawamura Y; Ukai S; Sagou K; Fukuyama R; Kohno A; Ozeki K
    Rinsho Ketsueki; 2021; 62(4):245-250. PubMed ID: 33967147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MYC-containing double minutes in hematologic malignancies: evidence in favor of the episome model and exclusion of MYC as the target gene.
    Storlazzi CT; Fioretos T; Surace C; Lonoce A; Mastrorilli A; Strömbeck B; D'Addabbo P; Iacovelli F; Minervini C; Aventin A; Dastugue N; Fonatsch C; Hagemeijer A; Jotterand M; Mühlematter D; Lafage-Pochitaloff M; Nguyen-Khac F; Schoch C; Slovak ML; Smith A; Solè F; Van Roy N; Johansson B; Rocchi M
    Hum Mol Genet; 2006 Mar; 15(6):933-42. PubMed ID: 16452126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amplification of c-MYC oncogene and point mutation of N-RAS oncogene point mutation in acute myelocytic leukemias with double minute chromosomes.
    Tanaka K; Takechi M; Nishimura S; Oguma N; Kamada N
    Leukemia; 1993 Mar; 7(3):469-71. PubMed ID: 8445953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amplification of the MLL gene on double minutes, a homogeneously staining region, and ring chromosomes in five patients with acute myeloid leukemia or myelodysplastic syndrome.
    Streubel B; Valent P; Jäger U; Edelhäuser M; Wandt H; Wagner T; Büchner T; Lechner K; Fonatsch C
    Genes Chromosomes Cancer; 2000 Apr; 27(4):380-6. PubMed ID: 10719368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct sequences on 11q13.5 and 11q23-24 are frequently coamplified with MLL in complexly organized 11q amplicons in AML/MDS patients.
    Zatkova A; Ullmann R; Rouillard JM; Lamb BJ; Kuick R; Hanash SM; Schnittger S; Schoch C; Fonatsch C; Wimmer K
    Genes Chromosomes Cancer; 2004 Apr; 39(4):263-76. PubMed ID: 14978788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Karyotype is prognostically more important than the FAB system's distinction between myelodysplastic syndrome and acute myelogenous leukemia.
    Estey EH; Keating MJ; Dixon DO; Trujillo JM; McCredie KB; Freireich EJ
    Hematol Pathol; 1987; 1(4):203-8. PubMed ID: 3504436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathologic analysis of acute myeloid leukemia arising from chronic myelomonocytic leukemia.
    Courville EL; Wu Y; Kourda J; Roth CG; Brockmann J; Muzikansky A; Fathi AT; de Leval L; Orazi A; Hasserjian RP
    Mod Pathol; 2013 Jun; 26(6):751-61. PubMed ID: 23307061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential regulation of the c-Myc/Lin28 axis discriminates subclasses of rearranged MLL leukemia.
    Chen L; Sun Y; Wang J; Jiang H; Muntean AG
    Oncotarget; 2016 May; 7(18):25208-23. PubMed ID: 27007052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia-related changes and normal karyotype.
    Prats-Martín C; Burillo-Sanz S; Morales-Camacho RM; Pérez-López O; Suito M; Vargas MT; Caballero-Velázquez T; Carrillo-Cruz E; González J; Bernal R; Pérez-Simón JA
    Cancer Med; 2020 Jun; 9(11):3637-3646. PubMed ID: 32216059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AML/MDS with 11q/MLL amplification show characteristic gene expression signature and interplay of DNA copy number changes.
    Zatkova A; Merk S; Wendehack M; Bilban M; Muzik EM; Muradyan A; Haferlach C; Haferlach T; Wimmer K; Fonatsch C; Ullmann R
    Genes Chromosomes Cancer; 2009 Jun; 48(6):510-20. PubMed ID: 19306356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unusual intracytoplasmic crystalline inclusions in chronic myelomonocytic leukemia with double minute chromosomes and MYC amplification: a rare case.
    Miyazaki K; Suzuki K
    Acta Haematol; 2014; 132(1):68-72. PubMed ID: 24481037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. t(11;16)(q23;p13)/KMT2A-CREBBP in hematologic malignancies: presumptive evidence of myelodysplasia or therapy-related neoplasm?
    Xie W; Tang G; Wang E; Kim Y; Cloe A; Shen Q; Zhou Y; Garcia-Manero G; Loghavi S; Hu AY; Wang S; Bueso-Ramos CE; Kantarjian HM; Medeiros LJ; Hu S
    Ann Hematol; 2020 Mar; 99(3):487-500. PubMed ID: 32006151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical and Cytogenetic Characteristics of Two AML Patients with High-level MLL Expression].
    Zhao JW; Ru K; Li CW; Tang KJ; Zheng YC; Cui CH; Xiao J; Chen SH; Wang XJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):683-687. PubMed ID: 28641618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High Expression of Human Homologue of Murine Double Minute 4 and the Short Splicing Variant, HDM4-S, in Bone Marrow in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome.
    Han X; Medeiros LJ; Zhang YH; You MJ; Andreeff M; Konopleva M; Bueso-Ramos CE
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S30-8. PubMed ID: 27155969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression analyses identify MLL as a prominent target of 11q23 amplification and support an etiologic role for MLL gain of function in myeloid malignancies.
    Poppe B; Vandesompele J; Schoch C; Lindvall C; Mrozek K; Bloomfield CD; Beverloo HB; Michaux L; Dastugue N; Herens C; Yigit N; De Paepe A; Hagemeijer A; Speleman F
    Blood; 2004 Jan; 103(1):229-35. PubMed ID: 12946992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel variant form of MLL-ELL fusion transcript with t(11;19)(q23;p13.1) in chronic myelomonocytic leukemia transforming to acute myeloid leukemia.
    Kakihana K; Kubo F; Wakabayashi S; Kurosu T; Miki T; Murakami N; Miura O
    Cancer Genet Cytogenet; 2008 Jul; 184(2):109-12. PubMed ID: 18617060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myelodysplastic syndromes with deletions of chromosome 11q lack cryptic MLL rearrangement and exhibit characteristic clinicopathologic features.
    Wang SA; Abruzzo LV; Hasserjian RP; Zhang L; Hu Y; Zhang Y; Zhao M; Galili N; Raza A; Medeiros LJ; Garcia-Manero G; Miranda RN
    Leuk Res; 2011 Mar; 35(3):351-7. PubMed ID: 20691474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amplified c-MYC sequences localized by fluorescence in-situ hybridization on double minute chromosomes in acute myeloid leukemias.
    Fugazza G; Bruzzone R; Puppo L; Patrone F; Sessarego M
    Leuk Res; 1997 Aug; 21(8):703-9. PubMed ID: 9379677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of MYC oncoprotein expression on survival outcome in patients with acute myeloid leukemia with myelodysplasia related changes (AML-MRC).
    Yun S; Sharma R; Chan O; Vincelette ND; Sallman DA; Sweet K; Padron E; Komrokji R; Lancet JE; Abraham I; Moscinski LC; Cleveland JL; List AF; Zhang L
    Leuk Res; 2019 Sep; 84():106194. PubMed ID: 31357093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 11q23 abnormalities in patients with acute myelogenous leukemia and myelodysplastic syndrome as detected by molecular and cytogenetic analyses.
    Ibrahim S; Estey EH; Pierce S; Glassman A; Keating M; O'Brien S; Kantarjian HM; Albitar M
    Am J Clin Pathol; 2000 Nov; 114(5):793-7. PubMed ID: 11068555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.